Filing under Rule 425 under the Securities Act
of 1933 and deemed filed under Rule 14a-12 of
the Securities Exchange Act of 1934
Filed by: Pershing Square Capital Management, L.P.
Subject Company: Valeant Pharmaceuticals International, Inc.
SEC File No. of Valeant Pharmaceuticals International, Inc.: 001-14956
Advancing Allergan Webcast Please return July 17, 2014 8:30 Am EST Questions@advancingallergan.com AGN Webcast Event starts Thu Jul, 17 2014 8:30 AM EDT PERSING SQUARE
S4
M??D`VN`4'?K]'LI_!G]-(#1<``````````6[&-J,WR;'IF06>&A^VP3<)U2G
M-+BE-(UK2VBAZCH%_AMU3D6^*[3&:H_(?*7*`D\>QF_Y'<4VVQP79\Q7'HVB
MX)3SJ6HZ)27SF+1;,JS=$,DH[+.[*D$K1;4F95Z-4M6KYN#1E_XBLK0Q_EN$
MY3B5P]1R"`Y#=54V7#\9ITBYVW"X*_?\@K%\3-.*TVS&*0Q7:S-.<28VST,LH+C"&4-.N:3
^U^]FH^_(!M<`H
M._7Z/93^#/Z:0&BX````````";L>$9??HJY=EM+\^*TOHG'FM&DETKI\92>-
M#$S;,17G15U7W$
AB.JU*9Z-TVHBUNFA"&$+(O',Z\:"]/%=/-'97#/J
M4LGP6QSW?G3K?U<5]RZR9% .XO%N<9%JBW%N[(2S).2;J5=$7*V1M*3XJN?F?M\W"9EV67:++9(MBC7-XG[JJ.I:UO*2>HD$I9JT-DKCI(5FW"
M(X0M%U)F>,\N]"HR.2G%'L:Z%LXKTU$]4@]72$M#?1D@N.G33CR5$S%:=%>^
MGN5C"O3[/S>O%LZON.WB/